David Ian Quinn


Ontology type: schema:Person     


Person Info

NAME

David Ian

SURNAME

Quinn

Publications in SciGraph latest 50 shown

  • 2022-05-16 Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer in CURRENT ONCOLOGY REPORTS
  • 2021-05-24 Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors in INVESTIGATIONAL NEW DRUGS
  • 2021-01-06 Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the urothelium – an NCI-CTEP sponsored: California Cancer Consortium trial, NCI 6879 in INVESTIGATIONAL NEW DRUGS
  • 2020-05-29 Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma in INVESTIGATIONAL NEW DRUGS
  • 2020-03-03 Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2020-02-28 Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2020-02-13 Survival outcomes and risk group validation from SWOG S0925: a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancer in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2019-12-20 The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC) in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2019-11-11 Radium-223 mechanism of action: implications for use in treatment combinations in NATURE REVIEWS UROLOGY
  • 2019-08-14 p53 nuclear accumulation as an early indicator of lethal prostate cancer in BRITISH JOURNAL OF CANCER
  • 2019-06-06 A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma in INVESTIGATIONAL NEW DRUGS
  • 2018-09-20 SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer in WORLD JOURNAL OF UROLOGY
  • 2018-06-13 Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421) in JOURNAL OF PATIENT-REPORTED OUTCOMES
  • 2018-01-31 HER kinase inhibition in patients with HER2- and HER3-mutant cancers in NATURE
  • 2017-01-05 Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2016-11-15 Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-06-10 Safety and feasibility of fasting in combination with platinum-based chemotherapy in BMC CANCER
  • 2015-11-04 Immune response from STRIDE, a randomized, Phase II, open-label study of sipuleucel-T (sip-T) with concurrent vs sequential enzalutamide (enz) administration in metastatic castration-resistant prostate cancer (mCRPC) in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-09-11 Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2015-07-16 Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinoma in BRITISH JOURNAL OF CANCER
  • 2015 Emerging Agents in Renal Cell Carcinoma in KIDNEY CANCER
  • 2014-12-16 Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review in BMC CANCER
  • 2014-11-06 Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2014-09-23 A Phase II trial of a combination herbal supplement for men with biochemically recurrent prostate cancer in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2014-03-05 Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial in TARGETED ONCOLOGY
  • 2014-01-27 Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-02-17 A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors in INVESTIGATIONAL NEW DRUGS
  • 2011-11-29 Emerging Agents in Renal Cell Carcinoma in KIDNEY CANCER
  • 2011-03-23 A phase II trial of gefitinib and pegylated IFNα in previously treated renal cell carcinoma in INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • 2009-03 Effect of the Cytochrome P450 2C19 Inhibitor Omeprazole on the Pharmacokinetics and Safety Profile of Bortezomib in Patients with Advanced Solid Tumours, Non-Hodgkin’s Lymphoma or Multiple Myeloma in CLINICAL PHARMACOKINETICS
  • 2008-11-20 Adjuvant chemotherapy for locally advanced urothelial carcinoma: an overview of the USC experience in WORLD JOURNAL OF UROLOGY
  • 2008-05-27 Erratum: The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro in BRITISH JOURNAL OF CANCER
  • 2008-03-18 The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro in BRITISH JOURNAL OF CANCER
  • 2007-06-14 A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2007-05-17 Oblimersen and α-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2006-01-13 Phase I clinical trial of weekly docetaxel and exisulind, a novel inducer of apoptosis in INVESTIGATIONAL NEW DRUGS
  • 2003-09-04 Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer in ONCOGENE
  • 2003-06-01 Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression in PROSTATE CANCER AND PROSTATIC DISEASES
  • 1997-11 Pharmacokinetic and Pharmacodynamic Principles of Illicit Drug Use and Treatment of Illicit Drug Users in CLINICAL PHARMACOKINETICS
  • Affiliations

  • University of Southern California (current)
  • University of Toronto
  • University of Arizona
  • Yale University
  • Addenbrooke's Hospital
  • Fondazione IRCCS Istituto Nazionale dei Tumori
  • Université Laval
  • University of Ulsan
  • City Of Hope National Medical Center
  • Georgetown University
  • University Hospital of Lord’s Transfiguration
  • Loyola University Chicago
  • University of Colorado Denver
  • University of Washington
  • University of California, Davis
  • Dartmouth–Hitchcock Medical Center
  • University Hospitals Bristol NHS Foundation Trust
  • Garvan Institute of Medical Research
  • University Medical Center Hamburg-Eppendorf
  • Royal Melbourne Hospital
  • Mount Sinai Hospital
  • University of Colorado Anschutz Medical Campus
  • Mount Vernon Hospital
  • Erasmus University Rotterdam
  • Helsinki University Hospital
  • Leicester Royal Infirmary
  • USC Norris Cancer Hospital
  • Royal Marsden Hospital
  • UNSW Sydney
  • Hôpital Saint-Louis
  • St Vincent's Hospital Sydney
  • National Cancer Institute
  • Royal Hospital for Women
  • New York Medical College
  • University of California Davis Medical Center
  • Aeterna Zentaris (Germany)
  • University of Michigan–Ann Arbor
  • Institute of Cancer Research
  • Macquarie University
  • Dana-Farber Cancer Institute
  • University of Manitoba
  • Harvard University
  • Memorial Sloan Kettering Cancer Center
  • UC Davis Health System
  • Northwestern University
  • Cornell University
  • Ottawa Hospital
  • Brigham and Women's Hospital
  • UC San Diego Health System
  • Institut Gustave Roussy
  • Cleveland Clinic
  • Guy's Hospital
  • Bayer (Germany)
  • Erasmus MC
  • Oregon Health & Science University
  • Pinnacle Oncology Hematology
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.42505.36", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.17063.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.134563.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.47100.32", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.120073.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.417893.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.23856.3a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.267370.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410425.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.213910.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.499063.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.164971.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.241116.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.34477.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.27860.3b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413480.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410421.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415306.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.13648.38", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416153.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416167.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.430503.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416188.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6906.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.15485.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419248.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.488628.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.424926.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.1005.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413328.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.437825.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.48336.3a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416139.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.260917.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413079.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.476147.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.214458.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.18886.3f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.1004.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.21613.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.38142.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.416958.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.16753.36", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5386.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412687.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.62560.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.420234.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14925.3b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.239578.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.239826.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.420044.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5645.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5288.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.492843.0", 
            "type": "Organization"
          }
        ], 
        "familyName": "Quinn", 
        "givenName": "David Ian", 
        "id": "sg:person.01013134010.15", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0002-1411-0417"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013134010.15", 
          "https://orcid.org/0000-0002-1411-0417"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-08-04T17:37", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/person/person_630.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01013134010.15'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01013134010.15'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01013134010.15'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01013134010.15'


     

    This table displays all metadata directly associated to this object as RDF triples.

    131 TRIPLES      11 PREDICATES      68 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01013134010.15 schema:affiliation N26f68869c88d40d39f9abed1836eccf9
    2 grid-institutes:grid.1004.5
    3 grid-institutes:grid.1005.4
    4 grid-institutes:grid.120073.7
    5 grid-institutes:grid.134563.6
    6 grid-institutes:grid.13648.38
    7 grid-institutes:grid.14925.3b
    8 grid-institutes:grid.15485.3d
    9 grid-institutes:grid.164971.c
    10 grid-institutes:grid.16753.36
    11 grid-institutes:grid.17063.33
    12 grid-institutes:grid.18886.3f
    13 grid-institutes:grid.213910.8
    14 grid-institutes:grid.214458.e
    15 grid-institutes:grid.21613.37
    16 grid-institutes:grid.23856.3a
    17 grid-institutes:grid.239578.2
    18 grid-institutes:grid.239826.4
    19 grid-institutes:grid.241116.1
    20 grid-institutes:grid.260917.b
    21 grid-institutes:grid.267370.7
    22 grid-institutes:grid.27860.3b
    23 grid-institutes:grid.34477.33
    24 grid-institutes:grid.38142.3c
    25 grid-institutes:grid.410421.2
    26 grid-institutes:grid.410425.6
    27 grid-institutes:grid.412687.e
    28 grid-institutes:grid.413079.8
    29 grid-institutes:grid.413328.f
    30 grid-institutes:grid.413480.a
    31 grid-institutes:grid.415306.5
    32 grid-institutes:grid.416139.8
    33 grid-institutes:grid.416153.4
    34 grid-institutes:grid.416167.3
    35 grid-institutes:grid.416188.2
    36 grid-institutes:grid.416958.7
    37 grid-institutes:grid.417893.0
    38 grid-institutes:grid.419248.2
    39 grid-institutes:grid.420044.6
    40 grid-institutes:grid.420234.3
    41 grid-institutes:grid.424926.f
    42 grid-institutes:grid.430503.1
    43 grid-institutes:grid.437825.f
    44 grid-institutes:grid.47100.32
    45 grid-institutes:grid.476147.7
    46 grid-institutes:grid.48336.3a
    47 grid-institutes:grid.488628.8
    48 grid-institutes:grid.492843.0
    49 grid-institutes:grid.499063.1
    50 grid-institutes:grid.51462.34
    51 grid-institutes:grid.5288.7
    52 grid-institutes:grid.5386.8
    53 grid-institutes:grid.5645.2
    54 grid-institutes:grid.62560.37
    55 grid-institutes:grid.65499.37
    56 grid-institutes:grid.6906.9
    57 schema:familyName Quinn
    58 schema:givenName David Ian
    59 schema:identifier N6234f1ac5e34469d8a1a3351926ebf46
    60 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013134010.15
    61 https://orcid.org/0000-0002-1411-0417
    62 schema:sdDatePublished 2022-08-04T17:37
    63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    64 schema:sdPublisher Ne512689321fa4338a43f322510e1951c
    65 sgo:license sg:explorer/license/
    66 sgo:sdDataset persons
    67 rdf:type schema:Person
    68 N26f68869c88d40d39f9abed1836eccf9 schema:affiliation grid-institutes:grid.42505.36
    69 sgo:isCurrent true
    70 rdf:type schema:OrganizationRole
    71 N6234f1ac5e34469d8a1a3351926ebf46 schema:name orcid_id
    72 schema:value 0000-0002-1411-0417
    73 rdf:type schema:PropertyValue
    74 Ne512689321fa4338a43f322510e1951c schema:name Springer Nature - SN SciGraph project
    75 rdf:type schema:Organization
    76 grid-institutes:grid.1004.5 schema:Organization
    77 grid-institutes:grid.1005.4 schema:Organization
    78 grid-institutes:grid.120073.7 schema:Organization
    79 grid-institutes:grid.134563.6 schema:Organization
    80 grid-institutes:grid.13648.38 schema:Organization
    81 grid-institutes:grid.14925.3b schema:Organization
    82 grid-institutes:grid.15485.3d schema:Organization
    83 grid-institutes:grid.164971.c schema:Organization
    84 grid-institutes:grid.16753.36 schema:Organization
    85 grid-institutes:grid.17063.33 schema:Organization
    86 grid-institutes:grid.18886.3f schema:Organization
    87 grid-institutes:grid.213910.8 schema:Organization
    88 grid-institutes:grid.214458.e schema:Organization
    89 grid-institutes:grid.21613.37 schema:Organization
    90 grid-institutes:grid.23856.3a schema:Organization
    91 grid-institutes:grid.239578.2 schema:Organization
    92 grid-institutes:grid.239826.4 schema:Organization
    93 grid-institutes:grid.241116.1 schema:Organization
    94 grid-institutes:grid.260917.b schema:Organization
    95 grid-institutes:grid.267370.7 schema:Organization
    96 grid-institutes:grid.27860.3b schema:Organization
    97 grid-institutes:grid.34477.33 schema:Organization
    98 grid-institutes:grid.38142.3c schema:Organization
    99 grid-institutes:grid.410421.2 schema:Organization
    100 grid-institutes:grid.410425.6 schema:Organization
    101 grid-institutes:grid.412687.e schema:Organization
    102 grid-institutes:grid.413079.8 schema:Organization
    103 grid-institutes:grid.413328.f schema:Organization
    104 grid-institutes:grid.413480.a schema:Organization
    105 grid-institutes:grid.415306.5 schema:Organization
    106 grid-institutes:grid.416139.8 schema:Organization
    107 grid-institutes:grid.416153.4 schema:Organization
    108 grid-institutes:grid.416167.3 schema:Organization
    109 grid-institutes:grid.416188.2 schema:Organization
    110 grid-institutes:grid.416958.7 schema:Organization
    111 grid-institutes:grid.417893.0 schema:Organization
    112 grid-institutes:grid.419248.2 schema:Organization
    113 grid-institutes:grid.420044.6 schema:Organization
    114 grid-institutes:grid.420234.3 schema:Organization
    115 grid-institutes:grid.424926.f schema:Organization
    116 grid-institutes:grid.42505.36 schema:Organization
    117 grid-institutes:grid.430503.1 schema:Organization
    118 grid-institutes:grid.437825.f schema:Organization
    119 grid-institutes:grid.47100.32 schema:Organization
    120 grid-institutes:grid.476147.7 schema:Organization
    121 grid-institutes:grid.48336.3a schema:Organization
    122 grid-institutes:grid.488628.8 schema:Organization
    123 grid-institutes:grid.492843.0 schema:Organization
    124 grid-institutes:grid.499063.1 schema:Organization
    125 grid-institutes:grid.51462.34 schema:Organization
    126 grid-institutes:grid.5288.7 schema:Organization
    127 grid-institutes:grid.5386.8 schema:Organization
    128 grid-institutes:grid.5645.2 schema:Organization
    129 grid-institutes:grid.62560.37 schema:Organization
    130 grid-institutes:grid.65499.37 schema:Organization
    131 grid-institutes:grid.6906.9 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...